Laurence Reid

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Matthew L. Wein, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Laurence Reid:

Company Role Class Num Shares Value Price $ Report Date Ownership
Metagenomi, Inc. Director Stock Option (Right to Buy) 42,000 02 Sep 2025 Direct
KalVista Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 17,000 23 Nov 2024 Direct
Decibel Therapeutics, Inc. President and Chief Executive Officer, Director Common Stock 0 $5.03 25 Sep 2023 Direct
Decibel Therapeutics, Inc. President and Chief Executive Officer, Director Stock Option (right to buy) 0 25 Sep 2023 Direct

Insider Reports Filed by Laurence Reid

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MGX Metagenomi, Inc. 02 Sep 2025 1 $0 4 Director 02 Sep 2025, 16:44
MGX Metagenomi, Inc. 11 Aug 2025 0 $0 3 Director 15 Aug 2025, 15:36
KALV KalVista Pharmaceuticals, Inc. 23 Nov 2024 1 $0 4 Director 26 Nov 2024, 16:41
KALV KalVista Pharmaceuticals, Inc. 23 Nov 2024 0 $0 3 Director 26 Nov 2024, 16:39
/report/000089924323019490-reid-laurence-2023-09-25 Decibel Therapeutics, Inc. 25 Sep 2023 4 $0 4 President and Chief Executive Officer, Director 25 Sep 2023, 16:25
/report/000089924323008873-reid-laurence-2023-03-16 Decibel Therapeutics, Inc. 16 Mar 2023 2 $0 4 President and Chief Executive Officer, Director 17 Mar 2023, 16:24
/report/000089924322008086-reid-laurence-2022-02-25 Decibel Therapeutics, Inc. 25 Feb 2022 1 $0 4 President and Chief Executive Officer, Director 28 Feb 2022, 15:36
/report/000089924321036500-reid-laurence-2021-09-15 Decibel Therapeutics, Inc. 15 Sep 2021 1 +$76,400 4 President and Chief Executive, Director 17 Sep 2021, 21:48